基本信息:
- 专利标题: 四象医学により処方可能な韓方薬肥満治療タブレット製剤の製造方法
- 申请号:JP2020536538 申请日:2018-12-20
- 公开(公告)号:JP2021508721A 公开(公告)日:2021-03-11
- 发明人: イム,ヨン ウ , オク,ジ ミョン , イ,ウン ホ , キム,ヨン ビン
- 申请人: ヌベベ カンパニー リミテッド , NUBEBE CO.,LTD. , ヒューマン ハーブ カンパニー リミテッド , HUMAN HERB CO.,LTD.
- 申请人地址: 大韓民国 13506 キョンギ−ド,ソンナム−シ,プンダン−グ,ソンナム−デロ 926ボン−ギル,10,2フロアー
- 专利权人: ヌベベ カンパニー リミテッド,NUBEBE CO.,LTD.,ヒューマン ハーブ カンパニー リミテッド,HUMAN HERB CO.,LTD.
- 当前专利权人: ヌベベ カンパニー リミテッド,NUBEBE CO.,LTD.,ヒューマン ハーブ カンパニー リミテッド,HUMAN HERB CO.,LTD.
- 当前专利权人地址: 大韓民国 13506 キョンギ−ド,ソンナム−シ,プンダン−グ,ソンナム−デロ 926ボン−ギル,10,2フロアー
- 代理人: 特許業務法人藤本パートナーズ
- 优先权: KR10-2017-0183328 2017-12-29 KR10-2018-0143446 2018-11-20
- 国际申请: KR2018016341 JP 2018-12-20
- 国际公布: WO2019132416 JP 2019-07-04
- 主分类号: A61K31/137
- IPC分类号: A61K31/137 ; A61P3/04 ; A61P43/00 ; A61K9/28 ; A61K36/8994 ; A61K36/076 ; A61K36/539 ; A61K36/725 ; A61K36/8968 ; A61K36/79 ; A61K135/00 ; A61K131/00 ; A61K125/00 ; A61K36/17
An embodiment of the present invention provides a manufacturing method of an herbal medicinal tablet formulation for treating obesity which can be prescribed based on Sasang constitutional medicine, comprises manufacturing a concentrated and quantified ephedra powder agent so that an ephedrine content of ephedra, which differs from 0.5-2.5% depending on a producing district and collecting period, is 3.0-4.0%, determining a weight according to each constitution of Sasang constitutional medicine of the concentrated and quantified ephedra powder agent of which the ephedrine content is 3.0-4.0%, and manufacturing a side-effect-preventing powder agent for each constitution to prevent and suppress side effects according to constitution of Sasang constitutional medicine with respect to the weight of the ephedra powder agent, preparing the ephedra powder agent and the side-effect-preventing powder agent while varying a weight ratio therebetween in consideration of weight, obesity, constitution of Sasang constitutional medicine, and side effects while mixing the ephedra powder agent and the side-effect-preventing powder agent; tableting a mixture of the prepared ephedra powder agent and side-effect-preventing powder agent; coating the tableted ones after tableting; and after the coating, while sorting out defective ones from coated ones and packaging, displaying a label including information prepared according to weight, obesity, constitution of Sasang constitutional medicine, and side effects.
信息查询:
EspacenetIPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K31/00 | 含有机有效成分的医药配制品 |
--------A61K31/045 | .羟基化合物,例如醇类;其盐类,例如醇化物 |
----------A61K31/135 | ..有芳环的,例如美沙酮 |
------------A61K31/137 | ...芳基烷基胺,例如苯丙胺、肾上腺素、沙丁胺醇、麻黄碱 |